Evidence map›Paper›PMID 35120186›Full record

ArticlePloS one2022

Persons tested for SAR-CoV-2 at a military treatment facility in Hawaii.

Javier Barranco-Trabi, Stephen Morgan, Seema Singh, Jimmy Hill, Alexander Kayatani, Victoria Mank, Holly Nesmith, Heather Omara, Louis Tripoli, Michael Lustik and 3 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Javier Barranco-TrabiDepartment of Internal Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.ORCID 0000-0003-1351-7503
Stephen MorganDepartment of Infectious Control, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Seema SinghDepartment of Infectious Control, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Jimmy HillDepartment of Infectious Control, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Alexander KayataniDepartment of Microbiology, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Victoria MankDepartment of Internal Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Holly NesmithDepartment of Family Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Heather OmaraDepartment of Family Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Louis TripoliDepartment of Internal Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.ORCID 0000-0001-7816-9525
Michael LustikDepartment of Clinical Investigation, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Jennifer MaselDepartment of Infectious Disease, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Sharon ChiDepartment of Infectious Disease, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.
Viseth NgauyDepartment of Infectious Disease, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health inequalities based on race are well-documented, and the COVID-19 pandemic is no exception. Despite the advances in modern medicine, access to health care remains a primary determinant of health outcomes, especially for communities of color. African-Americans and other minorities are disproportionately at risk for infection with COVID-19, but this problem extends beyond access alone. This study sought to identify trends in race-based disparities in COVID-19 in the setting of universal access to care. Tripler Army Medical Center (TAMC) is a Department of Defense Military Treatment Facility (DoD-MTF) that provides full access to healthcare to active duty military members, beneficiaries, and veterans. We evaluated the characteristics of individuals diagnosed with SARS-CoV-2 infection at TAMC in a retrospective, case-controlled (1:1) study. Most patients (69%) had received a COVID-19 test within 3 days of symptom onset. Multivariable logistic regression analyses were used to identify factors associated with testing positive and to estimate adjusted odds ratios. African-American patients and patients who identified as "Other" ethnicities were two times more likely to test positive for SARS-CoV-2 relative to Caucasian patients. Other factors associated with testing positive include: younger age, male gender, previous positive test, presenting with >3 symptoms, close contact with a COVID-19 positive patient, and being a member of the US Navy. African-Americans and patients who identify as "Other" ethnicities had disproportionately higher rates of positivity of COVID-19. Although other factors contribute to increased test positivity across all patient populations, access to care does not appear to itself explain this discrepancy with COVID-19.

Indexed as

Case-Control StudiesCOVID-19COVID-19 TestingEthnicityFemaleHawaiiHumansMaleMilitary PersonnelRetrospective StudiesSARS-CoV-2

Identifiers

PMID35120186
PMCPMC8815911

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.